Skip to content

NuytsTech Security

  • Home
  • Terms of Use
    • Privacy Policy
  • Blog
  • Cloud Hosting
  • Contact

NuytsTech Security

  • Home
  • Terms of Use
    • Privacy Policy
  • Blog
  • Cloud Hosting
  • Contact
  • Vulnerabilities

CVE-2017-12720

by Fred · 15/02/2018

An Improper Access Control issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6. The FTP server on the pump does not require authentication if the pump is configured to allow FTP connections.

Date published : 2018-02-15

http://www.securityfocus.com/bid/100665

https://ics-cert.us-cert.gov/advisories/ICSMA-17-250-02A

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Bluesky (Opens in new window) Bluesky
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Mastodon (Opens in new window) Mastodon

Similar

Tags: Cybersecurity Alert

  • Next story CVE-2018-0515
  • Previous story CVE-2017-6230

Recent Posts

  • CVE-2025-7367
  • CVE-2025-7360
  • CVE-2025-7341
  • CVE-2025-7340
  • CVE-2025-5394
  • CVE-2025-5393
  • CVE-2025-6265
  • CVE-2025-53891
  • CVE-2025-53890
  • CVE-2025-53889
  • CVE-2025-53887
  • CVE-2025-53886
  • CVE-2025-53885
  • CVE-2025-53839
  • CVE-2025-53836
  • CVE-2025-53835
  • CVE-2025-53834
  • CVE-2025-53833
  • CVE-2025-53825
  • CVE-2025-53824
  • CVE-2025-53823
  • CVE-2025-53822
  • CVE-2025-53821
  • CVE-2025-53820
  • CVE-2025-53819
  • CVE-2025-53818
  • CVE-2025-53643
  • CVE-2025-53640
  • CVE-2025-53639
  • CVE-2025-53623

Categories

  • Critical cyberalert
  • Vulnerabilities

Tags

CISA Cybersecurity Alert Shields Up

© 1999-2025 NUYTSTECH. All Rights Reserved. Use of the CVE (Common Vulnerabilities and Exposures) from this non-profit website are subject to the terms of use.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.